GENE THERAPY

摘要

The invention relates to genetic modification of target cells, e.g. vascular cells, to inhibit excessive proliferation thereof, comprising transferring to the cells or progenitors thereof, a DNA sequence encoding a soluble form of FasR or FGFR-1 or a biologically active fragment or derivative thereof.